Chapter 10 - THE PATHOLOGY QUESTION
When Helen told me Marcus had asked about my pathology, my first reaction was confusion.
My appendix had ruptured.
The pathology report confirmed acute appendicitis.
Nothing about that seemed connected to PSIP-4.
Then Helen asked whether I remembered anyone discussing a tissue-retention consent with me.
I did not.
Hospitals routinely retained pathology specimens for diagnostic and regulatory reasons.
Research use was different.
Pathology had always seemed to me like the quietest part of medicine.
Specimens moved through rooms most patients never saw.
Labels, slides, blocks, stains, reports.
The work happened after tissue had already left the body.
That distance made it easy to forget the tissue still belonged to someone's story.
When Helen explained that part of my specimen had gone to a research biobank, I pictured the pathology block in a plastic tray.
A tiny piece of tissue that had once nearly killed me.
I had no sentimental attachment to an appendix.
That was not the point.
The point was choice.
If someone had asked whether leftover tissue could support infection research, I might have said yes.
That possibility made the violation sharper, not smaller.
Consent was not valuable only when a patient would refuse.
It was valuable because the answer belonged to the patient either way.
I asked pathology to explain what happened to tissue after ordinary diagnostic use.
The answer was procedural and reassuring.
Retention schedules existed.
Storage controls existed.
Research access required additional authority.
The problem was not that hospitals kept tissue.
The problem was that a research pathway had treated my disputed consent as permission.
Understanding the normal process made the abnormal one clearer.
Marcus seemed unable to understand that distinction.
He repeatedly defended decisions by saying I probably would have agreed.
Maybe I would have.
He still had no right to convert probability into permission.
That lesson later became one of the first slides in my consent training.
Likely yes is still not yes.
Helen said a portion of my discarded surgical tissue had been transferred to the transplant research biobank.
The transfer log listed C-417.
That chapter of the investigation also changed one quiet habit in me.
I stopped assuming that a documented process had actually been followed simply because the form looked complete.
From then on, I looked for the human decision underneath the paperwork.
Who asked.
Who answered.
Who had power.
Who had time to think.
Who benefited from speed.
Those questions became more important to me than any perfectly aligned signature line.
The authorization field referenced the same disputed research consent.
I felt physically ill.
"Why would a transplant project want appendix tissue?"
Helen explained that PSIP-4 had expanded beyond blood markers.
The team was exploring inflammatory tissue signatures that might help predict post-transplant infection risk.
Appendix tissue from a severe peritonitis case provided a rich inflammatory sample.
In scientific terms, I was useful.
In human terms, no one had asked me.
The biobank log showed my specimen had been processed three days after surgery.
Part remained at Metropolitan General.
Part had been sent to an affiliated university laboratory.
A derivative dataset later went to Orison.
My body had traveled farther through the project than Marcus ever traveled to my hospital room.
I said that out loud before I could stop myself.
Sarah closed her eyes.
"That sentence is going to keep me awake tonight."
It kept me awake too.
The pathology issue also revealed why Marcus brought it up.
He was trying to redirect blame.
According to his attorney, the tissue transfer had been initiated by Evelyn Price and approved by Adrian.
Marcus claimed he did not learn the specimen belonged to me until later.
That statement contradicted the message noting that C-417 was the spouse of a co-investigator.
It also contradicted his admission that he knew my research code.
But timing mattered.
Maybe he knew later.
Maybe not before the tissue transfer.
Helen's team began reconstructing the exact moment Marcus learned C-417 was me.
The earliest confirmed proof came from an internal project chat sent twelve hours after enrollment.
Adrian wrote, M knows spouse is in cohort.
That was after the initial blood draw but before the tissue left pathology storage.
So even under the most generous interpretation, Marcus knew before part of my specimen was transferred to the university lab.
He did nothing to stop it.
He did not disclose the conflict.
He did not ask for my consent.
He did not remove himself from decisions involving my record.
Instead, his access intensified.
The chart logs showed fourteen of his forty-seven accesses occurred after that message.
The pathology trail also exposed another weakness in the study.
Three tissue samples from other patients had been moved under broad clinical-consent language rather than explicit research authorization.
The institutional review board called an emergency session.
The study's approval was suspended in full.
The hospital began notifying affected patients or their representatives.
That was when the families entered the story.
One of the two patients who had died was a sixty-eight-year-old teacher named Margaret Ellis.
Her daughter, Rachel, contacted an attorney after receiving the hospital notice.
I learned her name only because her attorney later filed a public petition seeking preservation of records.
The filing alleged that Margaret had been enrolled in PSIP-4 while receiving heavy sedation after bowel surgery.
Her imaging was delayed six hours around a research collection window.
She later developed septic shock and died.
The petition did not claim the delay caused her death.
It claimed the family deserved to know whether research priorities influenced her care.
I read that sentence twice.
That was exactly the question I had been asking about myself.
Rachel's case made the scandal public.
Local reporters connected the research suspension to the court filing.
Marcus's name appeared in print for the first time.
So did Adrian's.
My name did not.
I wanted it that way.
Then a reporter left a voicemail for Sarah asking whether "Dr. Hayes's estranged wife" was Patient C-417.
Someone had leaked the code.
Sarah told the reporter we had no comment.
Within hours, another outlet called.
Then another.
By evening, three reporters were waiting outside my apartment building.
I watched them from the twenty-second floor.
Cameras under umbrellas.
Phones pressed to ears.
Strangers hoping my worst month could become a clean headline.
I closed the curtains.
Marcus's attorney issued a statement saying he had always acted in the best interests of patients and strongly denied any suggestion that research considerations compromised care.
The statement described the review as complex and ongoing.
It asked the public to avoid judgment based on incomplete information.
That part was fair.
I hated that it was fair.
Truth did not become stronger because I hated him.
If anything, my hatred made discipline more important.
So I did not speak publicly.
I did not post online.
I did not leak messages.
I let records speak where they were legally supposed to speak.
Marcus interpreted my silence as weakness.
At least that was how Sarah read his next move.
He filed an amended divorce petition alleging that I had emotionally abandoned the marriage before hospitalization and had used the medical crisis as a pretext to leave.
He sought a larger share of the home equity based on what he called my "professional misconduct and reputational harm."
I laughed when Sarah told me.
Not because it was funny.
Because the alternative was screaming.
"He offered me the whole house last week."
"Settlement positions are confidential and generally inadmissible for this purpose."
"I know."
"I still hate it."
"Also normal."
Then Sarah showed me the attached declaration.
Marcus claimed I had become distant months before my illness.
He said I resented his success.
He said I criticized the transplant initiative because I had not been chosen for a leadership role.
That allegation was ridiculous.
I had declined two invitations to join the program's governance committee because of workload.
Sarah had the emails.
I had kept them.
Marcus should have known I kept everything.
But one part of his declaration was new.
He claimed that three weeks before my appendix ruptured, I threatened to report him for using Orison.
I had no memory of such a threat.
We had argued about data governance at dinner.
I remembered that.
He told me innovation could not wait for "every compliance box to feel emotionally safe."
I told him bypassing approvals was not innovation.
Then he changed the subject.
Had I threatened to report him?
No.
At least I did not think so.
The question bothered me enough that I searched my personal email archive.
I found nothing.
Then Leo called.
Hospital forensics had recovered Evelyn's deleted voice message.
The recording was twenty-eight seconds long.
Marcus's voice was clear.
He said, "Use the usual form."
He said, "She'll be out of it tonight."
Then he said the sentence that made Sarah stop taking notes.
"By the time Clara knows what she signed, the samples will already be banked."
There was no ambiguity left in the room.
No weak memory.
No misunderstanding.
No administrative cleanup.
Marcus had expected me not to know.
May you like
And he had counted on my illness to make that possible.
